(2021). Correction: Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer. BMJ Publishing Group.
Cita Chicago Style (17a ed.)Correction: Quantitative Systems Pharmacology Model Predictions for Efficacy of Atezolizumab and Nab-paclitaxel in Triple-negative Breast Cancer. BMJ Publishing Group, 2021.
Cita MLA (8a ed.)Correction: Quantitative Systems Pharmacology Model Predictions for Efficacy of Atezolizumab and Nab-paclitaxel in Triple-negative Breast Cancer. BMJ Publishing Group, 2021.
Precaución: Estas citas no son 100% exactas.